Search

Kevin James Vaska

from Sioux Falls, SD
Age ~68
Get Report
Also known as:
Kevin J Vaska, Kevin Dr Vaska, Kevin L Vaska, Kevin S Vaska, Kevin P Vaska, Kevin E Vaska
Phone and address:
3562 Spencer Blvd, Sioux Falls, SD 57103
(605) 332-6806
Related to:
Debra R BlumeyerCraig A Donovan, 68Patrick R Donovan, 35Joseph J Vaska, 29Mary E Donovan, 33Christopher VaskaPatrick Donovan, 38Colleen M Gabriel, 75Margaret A VaskaPatricia L Vaska, 66Robert J Donovan, 67Maureen Donovan, 38Anthony G Reu, 57
Connected to:
Janet P Vaskas, 72Adrian V Vaske, 76Chris J Vaske, 55Dawn M Vaske, 66Fred A Vaske, 71Leroy K Vaske, 67Valerie G Vaske, 63Vladimir Vaskevich, 47Angell L Vasko, 52Daria Vasko, 44

Kevin Vaska Phones & Addresses

  • 3562 Spencer Blvd, Sioux Falls, SD 57103 (605) 332-6806
  • 2409 Marson Dr, Sioux Falls, SD 57103 (605) 332-6806
  • 1310 22Nd St, Sioux Falls, SD 57105 (605) 782-2265
  • Brookfield, WI
  • Rochester, MN
  • Cleveland, OH
  • 3562 S Spencer Blvd, Sioux Falls, SD 57103 (605) 661-8222

Work

Company: Sioux Falls Cardiovascular Address: 6709 S Minnesota Ave, Sioux Falls, SD 57108 Phones: (605) 274-6300

Education

School / High School: Sanford School Of Medicine Of The University Of South Dakota 1982

Languages

English

Ranks

Certificate: Cardiovascular Disease, 1989

Specialities

Cardiology

Professional Records

License Records

Kevin James Vaska Md

License #:
26783 - Active
Category:
Medicine
Issued Date:
May 16, 2012
Effective Date:
May 16, 2012
Expiration Date:
Oct 1, 2018
Type:
Physician

Medicine Doctors

Kevin Vaska Photo 1

Dr. Kevin J Vaska, Sioux Falls SD - MD (Doctor of Medicine)

View page
Specialties:
Cardiology
Address:
Sioux Falls Cardiovascular
6709 S Minnesota Ave, Sioux Falls, SD 57108
(605) 274-6300 (Phone)
Procedures:
Ablation for Treatment of Cardiac Arrythmias
Cardiac Catheterization (incl. Coronary Angiography)
Cardiac Imaging
Cardiac Myocardial Perfusion Imaging
Cardioversion, Elective
Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
Chest CT (incl. Heart and Lungs)
Coronary Angioplasty, Atherectomy and Stent
Peripheral Artery Catheterization
Thrombolysis
Tilt Testing or Cardiac Event Monitors
Conditions:
Aneurysm and Dissection of Heart
Angina and Acute Coronary Syndrome
Aortic Aneurysm
Aortic Dissection
Aortic Valve Disease
Arrhythmias (incl. Atrial Fibrillation)
Autonomic Disorders
Cardiomegaly
Cardiomyopathy
Carotid Artery Disease
Congenital Heart Disease
Congestive Heart Failure
Coronary Artery Disease (CAD)
Endocarditis
Heart Attack (Acute Myocardial Infarction)
Hyperlipidemia
Hypertension
Hypertensive Heart and Chronic Kidney Disease
Hypertensive Heart Disease
Hypotension
Mitral Valve Disease
Pericardial Disease
Pulmonary Hypertension
Pulmonary Valve Disease
Septal Defect
Syncope
Tricuspid Valve Disease
Certifications:
Cardiovascular Disease, 1989
Internal Medicine, 1985
Languages:
English
Education:
Medical School
Sanford School Of Medicine Of The University Of South Dakota
Graduated: 1982
Medical School
Royal C Johnson Va Hospital
Graduated: 1983
Medical School
University Sd
Graduated: 1986
Medical School
Med College Of Wisconsin
Graduated: 1989
Background:
Sanction:  1 time(s)
Board Action:  1 time(s)
Kevin Vaska Photo 2

Kevin J. Vaska

View page
Specialties:
Cardiovascular Disease
Work:
Sioux Falls Cardiovascular
6709 S Minnesota Ave STE 101, Sioux Falls, SD 57108
(605) 274-6300 (phone), (877) 616-4723 (fax)
Education:
Medical School
University of South Dakota Sanford School of Medicine
Graduated: 1982
Procedures:
Cardioversion
Angioplasty
Cardiac Catheterization
Cardiac Stress Test
Continuous EKG
Echocardiogram
Electrocardiogram (EKG or ECG)
Pacemaker and Defibrillator Procedures
Pulmonary Function Tests
Vaccine Administration
Conditions:
Cardiomyopathy
Heart Failure
Abdominal Aortic Aneurysm
Acute Bronchitis
Acute Myocardial Infarction (AMI)
Languages:
English
Description:
Dr. Vaska graduated from the University of South Dakota Sanford School of Medicine in 1982. He works in Sioux Falls, SD and specializes in Cardiovascular Disease. Dr. Vaska is affiliated with Avera Heart Hospital, Avera Mckennan Hospital & University Health Center and Sioux Falls Specialty Hospital.
Kevin Vaska Photo 3

Kevin James Vaska, Sioux Falls SD

View page
Specialties:
Internal Medicine
Cardiovascular Disease
Cardiology
Work:
Sioux Falls Cardiovascular
6709 S Minnesota Ave, Sioux Falls, SD 57108
Sioux Falls Cardiovascular
1727 S Cleveland Ave, Sioux Falls, SD 57103
Avera Mckennan Hospital & University Health Center
1325 S Cliff Ave, Sioux Falls, SD 57105
Avera Heart Hospital of South Dakota Llc
4500 W 69Th St, Sioux Falls, SD 57108
Education:
University of South Dakota(1982)

Resumes

Resumes

Kevin Vaska Photo 4

Physician

View page
Location:
Sioux Falls, SD
Industry:
Medical Practice
Work:
Sioux Falls Cardiovascular
Physician
Usd School of Medicine Oct 1991 - Sep 2006
Physician
Education:
Usd School of Medicine 1978 - 1982
Doctor of Medicine, Doctorates, Medicine
Kevin Vaska Photo 5

Medical Doctor

View page
Work:

Medical Doctor

Business Records

Name / Title
Company / Classification
Phones & Addresses
Kevin Vaska
Medical Doctor, President
Kevin Vaska
Medical Doctor's Office · Internist
1727 S Cleveland Ave, Sioux Falls, SD 57103
6709 S Minnesota Ave, Sioux Falls, SD 57108
(605) 274-6300
Kevin Vaska
President
Sioux Falls Cardiovascular PC
Offices and Clinics of Medical Doctors · Offices and Clinics of Medical Doctors, Nsk
1727 S Cleveland Ave, Sioux Falls, SD 57103
6709 S Minnesota Ave, Sioux Falls, SD 57108
(605) 274-6300, (877) 233-3709

Publications

Us Patents

Bonding Tissues And Cross-Linking Proteins With Naphthalimide Compounds

View page
US Patent:
8242114, Aug 14, 2012
Filed:
Mar 19, 2009
Appl. No.:
12/407481
Inventors:
Ronald E. Utecht - Volga SD, US
Kaia L. Kloster - Hudson SD, US
Millard M. Judy - Redmond WA, US
Kevin J. Vaska - Sioux Falls SD, US
James L. Matthews - Dallas TX, US
Assignee:
Alumend LLC - Sioux Falls SD
International Classification:
A61K 31/55
US Classification:
5142295
Abstract:
Naphthalimide compounds are used in tissue bonding and protein cross-linking applications. When activated by an activating agent, such as light in the 400-500 nm absorption range, the naphthalimide compounds form chemically-reactive species that cross-link proteins, bond connective tissues together, and bond tissues and other biomaterials together. A naphthalimide-labeled biomolecule, such as a naphthalimide-labeled chitosan, is also capable of bonding tissues without subsequent direct illumination of the contacted tissue area. The naphthalimide compounds may be used in tissue or arterial repair, stabilization of an expanded arterial wall after angioplasty, tethering pharmaceutical agents to tissue surfaces to provide local drug delivery, and for chemically bonding skin care products, sunscreens, and cosmetics to the skin.

Bonding Tissues And Cross-Linking Proteins With Naphthalimide Compounds

View page
US Patent:
8546384, Oct 1, 2013
Filed:
Jul 12, 2012
Appl. No.:
13/547196
Inventors:
Ronald E. Utecht - Volga SD, US
Kaia L. Kloster - Hudson SD, US
Millard M. Judy - Redmond WA, US
Kevin J. Vaska - Sioux Falls SD, US
James L. Matthews - Dallas TX, US
Assignee:
Alumend, LLC - Sioux Falls SD
International Classification:
A61K 31/535
US Classification:
5142295
Abstract:
Naphthalimide compounds are used in tissue bonding and protein cross-linking applications. When activated by an activating agent, such as light in the 400-500 nm absorption range, the naphthalimide compounds form chemically-reactive species that cross-link proteins, bond connective tissues together, and bond tissues and other biomaterials together. A naphthalimide-labeled biomolecule, such as a naphthalimide-labeled chitosan, is also capable of bonding tissues without subsequent direct illumination of the contacted tissue area. The naphthalimide compounds may be used in tissue or arterial repair, stabilization of an expanded arterial wall after angioplasty, tethering pharmaceutical agents to tissue surfaces to provide local drug delivery, and for chemically bonding skin care products, sunscreens, and cosmetics to the skin.

Bonding Tissues And Cross-Linking Proteins With Naphthalimide Compounds

View page
US Patent:
8632565, Jan 21, 2014
Filed:
Feb 21, 2013
Appl. No.:
13/772543
Inventors:
Kaia L. Kloster - Hudson SD, US
Millard M. Judy - Redmond WA, US
Kevin J. Vaska - Sioux Falls SD, US
James L. Matthews - Dallas TX, US
Assignee:
Alumend, LLC - Sioux Falls SD
International Classification:
A61B 17/08
A61D 1/00
A61K 38/00
A01N 43/04
US Classification:
606214, 514 11, 514 55
Abstract:
Naphthalimide compounds are used in tissue bonding and protein cross-linking applications. When activated by an activating agent, such as light in the 400-500 nm absorption range, the naphthalimide compounds form chemically-reactive species that cross-link proteins, bond connective tissues together, and bond tissues and other biomaterials together. A naphthalimide-labeled biomolecule, such as a naphthalimide-labeled chitosan, is also capable of bonding tissues without subsequent direct illumination of the contacted tissue area. The naphthalimide compounds may be used in tissue or arterial repair, stabilization of an expanded arterial wall after angioplasty, tethering pharmaceutical agents to tissue surfaces to provide local drug delivery, and for chemically bonding skin care products, sunscreens, and cosmetics to the skin.

Bonding Tissues And Cross-Linking Proteins With Naphthalimide Compounds

View page
US Patent:
20050113288, May 26, 2005
Filed:
Nov 5, 2004
Appl. No.:
10/982197
Inventors:
Ronald Utecht - Volga SD, US
Kaia Kloster - Hudson SD, US
Millard Judy - Redmond WA, US
Kevin Vaska - Sioux Falls SD, US
James Matthews - Dallas TX, US
Assignee:
PhotoBioMed Corporation - Dallas TX
International Classification:
A61K038/17
C07K014/47
C08B037/08
US Classification:
514002000, 530409000, 536018700, 514055000, 536020000
Abstract:
Naphthalimide compounds are used in tissue bonding and protein cross-linking applications. When activated by an activating agent, such as light in the 400-500 nm absorption range, the naphthalimide compounds form chemically-reactive species that cross-link proteins, bond connective tissues together, and bond tissues and other biomaterials together. A naphthalimide-labeled biomolecule, such as a naphthalimide-labeled chitosan, is also capable of bonding tissues without subsequent direct illumination of the contacted tissue area. The naphthalimide compounds may be used in tissue or arterial repair, stabilization of an expanded arterial wall after angioplasty, tethering pharmaceutical agents to tissue surfaces to provide local drug delivery, and for chemically bonding skin care products, sunscreens, and cosmetics to the skin.

Bonding Tissues And Cross-Linking Proteins With Naphthalimide Compounds

View page
US Patent:
20130230472, Sep 5, 2013
Filed:
Feb 21, 2013
Appl. No.:
13/772510
Inventors:
Ronald E. Utecht - Volga SD, US
Kaia L. Kloster - Hudson SD, US
Millard M. Judy - Redmond WA, US
Kevin J. Vaska - Sioux Falls SD, US
James L. Matthews - Dallas TX, US
Assignee:
Alumend, LLC - Sioux Falls SD
International Classification:
A61K 41/00
A61K 8/73
A61Q 17/04
A61K 31/722
US Classification:
424 59, 514 55
Abstract:
Naphthalimide compounds are used in tissue bonding and protein cross-linking applications. When activated by an activating agent, such as light in the 400-500 nm absorption range, the naphthalimide compounds form chemically-reactive species that cross-link proteins, bond connective tissues together, and bond tissues and other biomaterials together. A naphthalimide-labeled biomolecule, such as a naphthalimide-labeled chitosan, is also capable of bonding tissues without subsequent direct illumination of the contacted tissue area. The naphthalimide compounds may be used in tissue or arterial repair, stabilization of an expanded arterial wall after angioplasty, tethering pharmaceutical agents to tissue surfaces to provide local drug delivery, and for chemically bonding skin care products, sunscreens, and cosmetics to the skin.

Bonding Tissues And Cross-Linking Proteins With Naphthalimide Compounds

View page
US Patent:
20190241680, Aug 8, 2019
Filed:
Aug 20, 2018
Appl. No.:
15/999547
Inventors:
- Sioux Falls SD, US
Kaia L. Kloster - Hudson SD, US
Millard M. Judy - Redmond WA, US
Kevin J. Vaska - Sioux Falls SD, US
James L. Matthews - Dallas TX, US
Assignee:
Alumend, LLC - Sioux Falls SD
International Classification:
C08B 37/08
A61B 17/00
A61K 41/00
A61K 47/61
A61L 24/08
A61K 8/73
A61K 31/722
A61Q 17/04
A61Q 19/00
A61N 5/06
A61B 17/08
Abstract:
Naphthalimide compounds as used in tissue bonding and protein cross-linking applications. When activated by an activating agent, such as light in the 400-500 nm absorption range, the naphthalimide compounds form chemically-reactive species that cross-link proteins, bond connective tissues together, and bone tissues and other biomaterials together. A naphthalimide-labeled biomolecule, such as a naphthalimide-labeled chitosan, is also capable of bonding tissues without subsequent direct illumination of the contacted tissue area. The naphthalimide compounds may be used in tissue or arterial repair, stabiliation of an expanded arterial wall after angioplasty, tethering pharmaceutical agents to tissue surfaces to provide local drug delivery, and for chemically bonding skin care products, sunscreens, and cosmetics to the skin.

Bonding Tissues And Cross-Linking Proteins With Naphthalimide Compounds

View page
US Patent:
20180079833, Mar 22, 2018
Filed:
Nov 17, 2017
Appl. No.:
15/815855
Inventors:
- Sioux Falls SD, US
Kaia L. Kloster - Hudson SD, US
Millard M. Judy - Redmond WA, US
Kevin J. Vaska - Sioux Falls SD, US
James L. Matthews - Dallas TX, US
Assignee:
Alumend, LLC - Sioux Falls SD
International Classification:
C08B 37/08
A61Q 19/00
A61Q 17/04
A61B 17/00
A61B 17/08
A61K 8/73
A61K 31/722
A61N 5/06
A61L 24/08
A61K 41/00
Abstract:
Naphthalimide compounds as used in tissue bonding and protein cross-linking applications. When activated by an activating agent, such as light in the 400-500 nm absorption range, the naphthalimide compounds form chemically-reactive species that cross-link proteins, bond connective tissues together, and bone tissues and other biomaterials together. A naphthalimide-labeled biomolecule, such as a naphthalimide-labeled chitosan, is also capable of bonding tissues without subsequent direct illumination of the contacted tissue area. The naphthalimide compounds may be used in tissue or arterial repair, stabilization of an expanded arterial wall after angioplasty, tethering pharmaceutical agents to tissue surfaces to provide local drug delivery, and for chemically bonding skin care products, sunscreens, and cosmetics to the skin.

Bonding Tissues And Cross-Linking Proteins With Naphthalimide Compounds

View page
US Patent:
20160068614, Mar 10, 2016
Filed:
Sep 2, 2015
Appl. No.:
14/843586
Inventors:
- Sioux Falls SD, US
Kaia L. Kloster - Hudson SD, US
Millard M. Judy - Redmond WA, US
Kevin J. Vaska - Sioux Falls SD, US
James L. Matthews - Dallas TX, US
Assignee:
ALUMEND, LLC - Sioux Falls SD
International Classification:
C08B 37/08
A61Q 17/04
A61K 8/73
Abstract:
Naphthalimide compounds are used in tissue bonding and protein cross-linking applications. When activated by an activating agent, such as light in the 400-500 nm absorption range, the naphthalimide compounds form chemically-reactive species that cross-link proteins, bond connective tissues together, and bond tissues and other biomaterials together. A naphthalimide-labeled biomolecule, such as a naphthalimide-labeled chitosan, is also capable of bonding tissues without subsequent direct illumination of the contacted tissue area. The naphthalimide compounds may be used in tissue or arterial repair, stabilization of an expanded arterial wall after angioplasty, tethering pharmaceutical agents to tissue surfaces to provide local drug delivery, and for chemically bonding skin care products, sunscreens, and cosmetics to the skin.
Control profile
Kevin James Vaska from Sioux Falls, SD, age ~68 Get Report